SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain
4 references·6 citing·37 second hop
Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain (2005)Review of the cost of diabetes complicati…The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004)The CORE Diabetes Model: Proj…Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data (2004)Modelling EuroQol health‐rela…Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…El coste de la diabetes tipo 2 en España. El estudio CODE-2 (2002)El coste de la diabetes tipo …Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up (2020)Health Care Costs Associated …The costs of treating long-term diabetic complications in a developing country: a study from India. (2013)The costs of treating long-te…Cost-of-illness study of type 2 diabetes mellitus in Colombia (2009)Cost-of-illness study of type…Cost-effectiveness of insulin analogues for diabetes mellitus (2009)Cost-effectiveness of insulin…Cost of medical care among type 2 diabetic patients with a co-morbid condition—Hypertension in India (2009)Cost of medical care among ty…Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data (2007)Estimating the Cost of Compli…Cost-Effectiveness in Health and Medicine (1996)Analysis of Panel Data (2003)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)A Comparison of United Kingdom and Spanish General Population Time Trade-off Values for EQ-5D Health States (2001)Direct Health Care Costs of Diabetic Patients in Spain (2004)Social economic costs and health‐related quality of life in patients with degenerative cerebellar ataxia in Spain (2007)Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain (2015)The cost of diabetes in Latin America and the Caribbean. (2003)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)A social tariff for EuroQol: results from a UK general population survey (1995)Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) (2002)Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes (2008)The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus (2010)Review of Utility Values for Economic Modeling in Type 2 Diabetes (2014)Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. (1998)Expenditure on health care incurred by diabetic subjects in a developing country — a study from southern India (2000)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)The prevalence and determinants of catastrophic health expenditures attributable to non-communicable diseases in low- and middle-income countries: a methodological commentary (2014)The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review (2017)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)An Introduction to Markov Modelling for Economic Evaluation (1998)Methods for the Economic Evaluation of Health Care Programmes (2005)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Markov Models in Medical Decision Making (1993)Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Increasing Expenditure on Health Care Incurred by Diabetic Subjects in a Developing Country (2007)Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010)The socioeconomics of diabetes from a developing country: A population based cost of illness study (2010)Out-of-pocket expenditure and drug adherence of patients with diabetes in Odisha (2018)Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country (2022)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Economic Costs of Diabetes in the U.S. in 2017 (2018)Economic Costs of Diabetes in the U.S. in 2012 (2013)The State of US Health, 1990-2010 (2013)Social Determinants of Health and Diabetes: A Scientific Review (2020)
this work references cited by second hop

References

  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 2004The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making528 cited
  • 2004Modelling EuroQol health‐related utility values for diabetic complications from CODE‐2 data261 cited
  • 2002El coste de la diabetes tipo 2 en España. El estudio CODE-2154 cited

Cited by

  • 2009Cost-effectiveness of insulin analogues for diabetes mellitus116 cited
  • 2013The costs of treating long-term diabetic complications in a developing country: a study from India.95 cited
  • 2007Estimating the Cost of Complications of Diabetes in Australia Using Administrative Health-Care Data84 cited
  • 2020Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up74 cited
  • 2009Cost-of-illness study of type 2 diabetes mellitus in Colombia63 cited
  • 2009Cost of medical care among type 2 diabetic patients with a co-morbid condition—Hypertension in India41 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work